Jump to content

Provigil: Narcolepsy Drug Fights Cancer Fatigue

Recommended Posts

http://www.webmd.com/cancer/news/200806 ... er-fatigue

Comment: My husband, who has been through many chemo regimens, has been experiencing, for the very fist time, a fatigue not known to him before this.

He is a fighter, and I wonder why this has not been offered as a help.


. . . . . . . .

(Chicago) -- The narcolepsy drug Provigil may help to relieve the debilitating fatigue often experienced by cancer patients undergoing chemotherapy, new research suggests.

"A majority of cancer patients expect they will experience fatigue and unfortunately, they're right," says Gary Morrow, MD, director of the University of Rochester Cancer Center.

A recent survey showed that nearly nine in 10 people with cancer suffer from lethargy and low energy levels during chemotherapy treatment.

Provigil is a member of a class of drugs called eugeroic agents that are used to treat narcolepsy and other sleep-related disorders. "They are basically non-amphetamine-based stimulants that improve wakefulness without causing addiction," Morrow tells WebMD.

Provigil Relieves Severe Fatigue

The new study, funded by the National Cancer Institute, involved 642 cancer patients who were undergoing chemotherapy for a variety of cancer types. About half were randomly assigned to take Provigil; the others got a placebo.

The patients were surveyed about fatigue, sleepiness, and depression at the time the trial started, when they were undergoing their second cycle of chemotherapy. They were surveyed again during the fourth cycle of chemotherapy.

Results showed that patients taking the drug who had the most severe fatigue at the beginning of the study demonstrated significant improvement, compared with those in the placebo group. Severe fatigue was defined as a rating of six or more on a 10-point scale, where 0 was no fatigue and 10 the worst possible fatigue imaginable.

Morrow says about 30% to 40% of cancer patients taking chemo report debilitating fatigue.

Patients with mild or moderate fatigue at the start of the study did not get the same relief from the drug.

The drug also had a significant benefit on sleepiness but had no effect on depression.

The findings were presented at the annual meeting of the American Society of Clinical Oncology.

"If the research is confirmed by other studies, Provigil may gain FDA approval for this use," Morrow says.

Nicholas Petrelli, MD, medical director of the Helen F. Graham Cancer Center in Wilmington, Del., says the findings are promising.

"There is a real need to find more agents that lessen fatigue and improve cancer patients' quality of life," he tells WebMD.

. . . . . . . .

(WebMD Health News, By Charlene Laino, and Reviewed by Louise Chang, MD, June 4, 2008)


The information contained in these articles may or may not be in agreement with my own opinions. They are not posted as medical advice of any kind.

Link to comment
Share on other sites


I recently tried to get my mom's dr. to prescibe this for her. He said there were too many side-effects. Of course, I wasn't there to press him for more information, but I believe it can make a huge difference for cancer patients. I think you should pursue it for your husband. I may try again in person for my mom on my next trip south to see her.

BTW, I have personal experience using it for depression and never had any side-effects.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.